Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer's disease
- PMID: 24252571
- PMCID: PMC3893394
- DOI: 10.1186/2051-5960-1-50
Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer's disease
Abstract
Background: We have sought histological evidence, using TDP-43 and p62 immunohistochemistry, for the presence of expansions in C9ORF72 among 200 patients with pathologically confirmed AD.
Results: We noted TDP-43 pathological changes in hippocampus and temporal cortex in 45 (22.5%) of these patients, but did not detect any cases where p62 positive changes in hippocampus and cerebellum, considered pathognomic for C9ORF72 expansions, were present.
Conclusion: We conclude that expansions in C9ORF72 associated with AD are a rare occurrence, and in those instances in the literature where these have been reported, the presence of AD may in fact be coincidental and unrelated to the expansion.
Similar articles
-
Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.Acta Neuropathol Commun. 2017 Apr 21;5(1):31. doi: 10.1186/s40478-017-0437-5. Acta Neuropathol Commun. 2017. PMID: 28431575 Free PMC article.
-
C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease.JAMA Neurol. 2013 Jun;70(6):736-41. doi: 10.1001/2013.jamaneurol.537. JAMA Neurol. 2013. PMID: 23588422 Free PMC article.
-
Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.Acta Neuropathol. 2012 Jun;123(6):825-39. doi: 10.1007/s00401-012-0970-z. Epub 2012 Mar 18. Acta Neuropathol. 2012. PMID: 22426854 Free PMC article.
-
The neuropathology associated with repeat expansions in the C9ORF72 gene.Acta Neuropathol. 2014 Mar;127(3):347-57. doi: 10.1007/s00401-013-1232-4. Epub 2013 Dec 20. Acta Neuropathol. 2014. PMID: 24356984 Review.
-
Meta-analysis of the association between C9orf72 repeats and neurodegeneration diseases.J Neurogenet. 2024 Mar;38(1):1-8. doi: 10.1080/01677063.2024.2343672. Epub 2024 May 20. J Neurogenet. 2024. PMID: 38767957 Review.
Cited by
-
Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD - a Systematic Review and Meta-Analysis.Cerebellum. 2022 Aug;21(4):681-714. doi: 10.1007/s12311-021-01320-0. Epub 2021 Sep 7. Cerebellum. 2022. PMID: 34491551 Free PMC article.
-
Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.Acta Neuropathol Commun. 2014 Jun 20;2:70. doi: 10.1186/2051-5960-2-70. Acta Neuropathol Commun. 2014. PMID: 24950788 Free PMC article.
-
From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases.J Bioenerg Biomembr. 2017 Oct;49(5):413-422. doi: 10.1007/s10863-017-9727-7. Epub 2017 Oct 3. J Bioenerg Biomembr. 2017. PMID: 28975445 Review.
-
Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.Acta Neuropathol Commun. 2013 Oct 14;1:68. doi: 10.1186/2051-5960-1-68. Acta Neuropathol Commun. 2013. PMID: 24252525 Free PMC article.
-
Distinct Phospho-TDP-43 brain distribution in two cases of FTD, one associated with ALS.Dement Neuropsychol. 2017 Jul-Sep;11(3):249-254. doi: 10.1590/1980-57642016dn11-030006. Dement Neuropsychol. 2017. PMID: 29213521 Free PMC article.
References
-
- Baborie A, Griffiths TD, Jaros E, Richardson A, Ferrari R, Moreno J, Momeni P, McKeith IG, Burn DJ, Duplessis D, Pal P, Rollinson S, Pickering-Brown SM, Thompson JC, Neary D, Snowden JS, Perry R, Mann DMA. Pathological correlates of Frontotemporal Lobar Degeneration in the elderly. Acta Neuropathol. 2011;1:365–373. - PubMed
-
- Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden M, Pickering-Brown SM, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, De Graaf E, Wauters E, Van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski JQ, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd P, Hayward N, Kwok JBJ, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, Van Swieten J, Mann DM, Lynch T, Heutink P. Association of missense and 5’–splice-site mutation in tau with inherited dementia FTDP-17. Nature. 1998;1:702–705. doi: 10.1038/31508. - DOI - PubMed
-
- Baker M, Mackenzie IRA, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M. Mutations in Progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;1:916–919. doi: 10.1038/nature05016. - DOI - PubMed
-
- Cruts M, Gijselinck I, Van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, Van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;1:920–924. doi: 10.1038/nature05017. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical